Target

Product NDC: 11673-912
11-digit product format: 116730912
Labeler code: 11673
Product ID: 11673-912_d3339a80-4ac1-43ac-8baa-0972000d09df
Type: HUMAN OTC DRUG
Nonproprietary name: Tolnaftate
Dosage form: CREAM
Route: TOPICAL
Labeler: Target Corporation
Application: part333C
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2006-02-17
Marketing end: 0000-00-00
Substance: TOLNAFTATE
Active strength: 10 mg/g
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	11673-912		I	Inactivated by FDA		2026-10-15
excluded package	package	11673-912	11673-912-02	I	Inactivated by FDA		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	11673-912-02	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	11673-912-02	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	11673-912-02	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	11673-912-02	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	11673-912-02	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	11673-912-02	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	11673-912-02	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	11673-912-02	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	11673-912-02	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2025-07-29	Target antifungal cream
2025-03-17	Target antifungal cream
2025-01-30	Target antifungal cream
2023-06-26	Target antifungal cream
2023-01-30	Target antifungal cream
2021-10-15	Target antifungal cream
2020-01-31	Target antifungal cream

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
11673-912-02	Targetantifungal	28.3 g in 1 TUBE	CREAM	28.3		5
11673-912-02	Targetantifungal	1 in 1 CARTON	CREAM	1		5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
11673-912-02	GM - Gram	11673-912	a68ccec5-0e33-425c-a9f0-c336a69d057e	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Tolnaftate	ACTIVE INGREDIENT	06KB629TKV	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2
Tolnaftate	ACTIVE MOIETY	06KB629TKV	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2
Butylated Hydroxytoluene	INACTIVE INGREDIENT	1P9D0Z171K	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2
Petrolatum	INACTIVE INGREDIENT	4T6H12BN9U	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2
Polyethylene Glycol 3350	INACTIVE INGREDIENT	G2M7P15E5P	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2
Polyethylene Glycol 400	INACTIVE INGREDIENT	B697894SGQ	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
11673-912	TARGET ANTIFUNGAL (TOLNAFTATE) CREAM [TARGET CORPORATION]	5	Legacy NDC, 2 package rows	20250321_f55c691f-5265-4574-8dc5-aa86b0a8edd2.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
06KB629TKV	TOLNAFTATE	2398-96-1	TOLNAFTATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
103951	tolnaftate 1 % Topical Cream	PSN	f55c691f-5265-4574-8dc5-aa86b0a8edd2	5
103951	tolnaftate 10 MG/ML Topical Cream	SCD	f55c691f-5265-4574-8dc5-aa86b0a8edd2	5
103951	tolnaftate 1 % Topical Cream	SY	f55c691f-5265-4574-8dc5-aa86b0a8edd2	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
11673-912-02	11673091202	1 TUBE in 1 CARTON (11673-912-02) > 28.3 g in 1 TUBE	1 tube	2006-02-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Target antifungal cream	Target Corporation \| Taro Pharmaceuticals Inc.	2025-03-17	HUMAN OTC DRUG LABEL	5